Evidence-Based Practice
Open Access Article

Putting Evidence Into Practice®: Evidence-Based Interventions for Cancer-Related Dyspnea

Wendye M. DiSalvo

Margaret M. Joyce

Leslie B. Tyson

Ann E. Culkin

Kathleen Mackay

interventions, dyspnea, opioid, oxygen inhalation therapy, complementary and alternative therapies, nebulizers and vaporizers
CJON 2008, 12(2), 341-352. DOI: 10.1188/08.CJON.341-352

Despite the common occurrence of cancer-related dyspnea, a paucity of literature is available for review, especially research literature that reports interventions to control dyspnea. The Oncology Nursing Society's Putting Evidence Into Practice® (PEP) initiative organized a team on nurses to examine the literature, rank the evidence, summarize the findings, and make recommendations for nursing practice to improve patient outcomes. Pharmacologic and nonpharmacologic agents have been used to treat dyspnea. Patients who received parenteral or oral immediate-release opioids demonstrated a benefit in the reduction of breathlessness; thus, parenteral or oral opioids are recommended for practice. Five interventions are listed in the effectiveness not established category and include extended-release morphine, midazolam plus morphine, nebulized opioids, the use of gas mixtures, and cognitive-behavioral therapy. This article critically examines the evidence, provides nurses with the best evidence for practice, and identifies gaps in the literature and opportunities for further research.

Jump to a section

    References

    Tanaka, K., Shima, Y., Kakinuma, R., Kubota, K., Ohe, Y., Hojo, F., et al. (1999). Effect of nebulized morphine in cancer patients with dyspnea: A pilot study. Japanese Journal of Clinical Oncology, 29(12), 600-603.
    Zeppetella, G. (1997). Nebulized morphine in palliation of dyspnoea. Palliative Medicine, 11(4), 267-275.
    Jennings, A. L., Davies, A. N., Higgins, J. P., Gibbs, J. S., & Broadley, K. E. (2002). A systematic review of the use of opioids in the management of dyspnoea. Thorax, 57(11), 939-944.
    Zeppetella, G. (1997). Nebulized morphine in the palliation of dyspnoea. Palliative Medicine, 11(4), 267-275.
    American Thoracic Society. (1999). Dyspnea. Mechanisms, assessment, and management: A consensus statement. American Journal of Respiratory and Critical Care Medicine, 159(1), 321-340.
    Ahmedzai, S. H., Laude, E., Robertson, A., Troy, G., & Vora, V. (2004). A double blind, randomized, controlled phase II trial of heliox 28 gas mixture in lung cancer patients with dyspnoea on exertion. British Journal of Cancer, 90(2), 366-371.
    Filshie, J., Penn, K., Ashley, S., & Davis, C. L. (1996). Acupuncture for the relief of cancer related breathlessness. Palliative Medicine, 10(2), 145-150.
    Ahmedzai, S. H., Laude, E., Robertson, A., Troy, G., & Vora, V. (2004). A double blind, randomized, controlled phase II trial of Heliox28 gas mixture in lung cancer patients with dyspnoea on exertion. British Journal of Cancer, 90(2), 366-371.
    Allard, P., Lamontagne, C., Bernard, P., & Tremblay, C. (1999). How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial. Journal of Pain and Symptom Management, 17(4), 256-265.
    American Thoracic Society. (1999). Dyspnea. Mechanisms, assessment, and management: A consensus statement. American Journal of Respiratory and Critical Care Medicine, 159(1), 321-340.
    Beckles, M. A., Spiro, S. G., Colice, G. L., & Rudd, R. M. (2003). Initial evaluation of the patient with lung cancer: Symptoms, signs, laboratory tests, and paraneoplastic syndromes. Chest, 123(1, Suppl.), 97S-104S.
    Borg, G. A. (1982). Psychophysical bases of perceived exertion. Medicine and Science in Sports and Exercise, 14(5), 377-381.
    Boyd, K. J., & Kelly, M. (1997). Oral morphine as symptomatic treatment of dsypnoea in patients with advanced cancer. Palliative Medicine, 11(4), 277-281.
    Bredin, M., Corner, J., Krishnasamy, M., Plant, H., Bailey, C., & A'Hern, R. (1999). Multicentre randomised controlled trial of nursing intervention for breathlesness in patients with lung cancer. British Medical Journal, 1(318), 901-904.
    Bruera, E., de Stoutz, N., Velasco-Leiva, A., Schoeller, T., & Hanson, J. (1993). Effects of oxygen on dyspnoea in hypoxaemic terminal-cancer patients. Lancet, 342(8862), 13-14.
    Bruera, E., MacEachern, T., Ripamonti, C., & Hanson, J. (1993). Subcutaneous morphine for dyspnea in cancer patients. Annals of Internal Medicine, 119(9), 906-907.
    Bruera, E., Macmillan, K., Pither, J., & MacDonald, R. N. (1990). Effects of morphine on the dyspnea of terminal cancer patients. Journal of Pain and Symptom Management, 5(6), 341-344.
    Bruera, E., Sala, R., Spruyt, O., Palmer, J. L., Zhang, T., & Willey, J. (2005). Nebulized versus subcutaneous morphine for patients with cancer dyspnea: A preliminary study. Journal of Pain and Symptom Management, 29(6), 613-618.
    Corner, J., Plant, H., A'Hern, R., & Bailey, C. (1996). Non-pharmacological intervention for breathlessness in lung cancer. Palliative Medicine, 10(4), 299-305.
    Coyne, P. J., Viswanathan, R., & Smith, T. J. (2002). Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate and oxygen saturation in dyspnea. Journal of Pain and Symptom Management, 23(2), 157-160.
    Filshie, J., Penn, K., Ashley, S., & Davis, C. L. (1996). Acupuncture for the relief of cancer-related breathlessness. Palliative Medicine, 10(2), 145-150.
    Gafford, J., & Searight, H. R. (2007). Psychological treatment of psychiatric disorders. Retrieved February 26, 2007, from http://patients.uptodate.com/topic.asp?file=psychiat/8326
    Given, B., Beck, S., Etland, C., Gobel, B. H., Lamkin, L., & Marsee, V. D. (n.d.). Nursing-sensitive patient outcomes. Retreived March 8, 2008, from http://www.ons.org/outcomes/measures/outcomes.shtml
    Goode, C. J. (2000). What constitutes the "evidence" in evidence-based practice? Applied Nursing Research, 13(4), 222-225.
    Hadorn, D. C., Baker, D., Hodges, J. S., & Hicks, N. (1996). Rating the quality of evidence for clinical practice guidelines. Journal of Clinical Epidemiology, 49(7), 749-754.
    Hately, J., Laurence, V., Scott, A., Baker, R., & Thomas, P. (2003). Breathlessness clinics within specialist palliative care settings can improve the quality of life and functional capacity of patients with lung cancer. Palliative Medicine, 17(5), 410-417.
    Jennings, A. L., Davies, A. N., Higgins, J. P.T., Gibbs, J. S.R., & Broadley, K. E. (2002). A systematic review of the use of opioids in the management of dyspnoea [Electronic version]. Thorax, 57, 939-944.
    Joyce, M., & Beck, S. L. (2005). Dyspnea evidence summary. Retrieved February 28, 2007, from http://www.ons.org/outcomes/measures/pdf/DyspneaEvidenceSummary.pdf
    Joyce, M., McSweeney, M., Carrieri-Kohlman, K. L., & Hawkins, J. (2004). The use of nebulized opioids in the management of dyspnea: Evidence synthesis. Oncology Nursing Forum, 31(3), 551-561.
    Kohara, H., Ueoka, H., Aoe, K., Maeda, T., Takeyama, H., Saito, R., et al. (2003). Effect of nebulized furosemide in terminally ill cancer patients with dyspnea. Journal of Pain and Symptom Management, 26(4), 962-967.
    Mazzocato, C., Buclin, T., & Rapin, C. H. (1999). The effects of morphine morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: A randomized double-blind controlled trial. Annals of Oncology, 10(12), 1511-1514.
    McKenry, L., & Salerno, E. (1992). Pharacology in nursing (18th ed.). St Louis, MO: Mosby.
    Mitchell, S. A., & Friese, C. R. (n.d.). Tables of evidence. Retrieved April 2, 2007, from http://www.ons.org/outcomes/tables/index.shtml
    National Comprehensive Cancer Network. (2006). Clinical Practice Guidelines in Oncology™: Palliative care [v.1.2006]. Retrieved January 18, 2007, from http://www.oralcancerfoundation.org/treatment/pdf/palliative.pdf
    Navigante, A. H., Cerchietti, L. C., Castro, M. A., Lutteral, M. A., & Cabalar, M. E. (2006). Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. Journal of Pain and Symptom Management, 31(1), 38-47.
    Quigley, C., Joel, S., Patel, N., Baksh, A., & Slevin, M. (2002). A phase I/II study of nebulized morphine-6-glucuronide in patients with cancer-related breathlessness. Journal of Pain and Symptom Management, 23(1), 7-9.
    Ripamonti, C., & Fusco, F. (2002). Respiratory problems in advanced cancer. Supportive Care in Cancer, 10(3), 204-216.
    Ropka, M. E., & Spencer-Cisek, P. (2001). PRISM: Priority Symptom Management Project Phase I: Assessment. Oncology Nursing Forum, 28(10), 1585-1594.
    Shimoyama, N., & Shimoyama, M. (2002). Nebulized furosemide as a novel treatment for dyspnea in terminal cancer patients. Journal of Pain and Symptom Management, 23(1), 73-76.
    Smith, E. L., Hann, D. M., Ahles, T. A., Furstenberg, C. T., Mitchell, T. A., Meyer, L., et al. (2001). Dyspnea, anxiety, body consciousness, and quality of life in patients with lung cancer. Journal of Pain and Symptom Management, 21(4), 323-329.
    Campbell, M. L. (2004). Terminal dyspnea and respiratory distress. Critical Care Clinics, 20(3), 403-417.
    Dudgeon, D. J. (2002). Managing dyspnea and cough. Hematology/Oncology Clinics of North America, 16(3), 557-577.
    Gallo-Silver, L., & Pollack, B. (2000). Behavioral interventions for lung cancer-related breathlessness. Cancer Practice, 8(6), 268-273.
    Bredin, M., Corner, J., Krishnasamy, M., Plant, H., Bailey, C., & A'Hern, R. (1999). Multicenter randomized controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ, 318(7188), 901-904.
    Corner, J., Plant, H., A'Hern, R., & Bailey, C. (1996). Non-pharmacological intervention for breathlessness in lung cancer. Palliative Medicine, 10(4), 299-305.
    Hately, J., Laurence, V., Scott, A., Baker, R., & Thomas, P. (2003). Breathlessness clinics within specialist palliative care settings can improve the quality of life and functional capacity of patients with lung cancer. Palliative Medicine, 17(5), 410-417.
    Allard, P., Lamontagne, C., Bernard, P., & Tremblay, C. (1999). How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial. Journal of Pain and Symptom Management, 17(4), 256-265.
    Mazzocato, C., Buclin, T., & Rapin, C. H. (1999). The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: A randomized double-blind controlled trial. Annals of Oncology, 10(12), 1511-1514.
    Bruera, E., Macmillan, K., Pither, J., & MacDonald, R. N. (1990). Effects of morphine on the dyspnea of terminal cancer patients. Journal of Pain and Symptom Management, 5(6), 341-344.
    National Comprehensive Cancer Network. (2006). Clinical practice guidelines in oncology: Palliative care, version 1.2006. Retrieved January 18, 2007, from http://www.nccn.org/professionals/physician_gls/PDF/palliative.pdf
    Bruera, E., de Stoutz, N., Velasco-Leiva, A., Schoeller, T., & Hanson, J. (1993). Effects of oxygen on dyspnea in hypoxaemic terminal-cancer patients. Lancet, 342(8862), 13-14.
    Bruera, E., Sweeney, C., Willey, J., Palmer, J. L., Strasser, F., Morice, R. C., et al. (2003). Randomized controlled trial of supplemental oxygen versus air in cancer patients with dyspnea. Palliative Medicine, 17(8), 659-663.
    Boyd, K. J., & Kelly, M. (1997). Oral morphine as symptomatic treatment of dyspnea in patients with advanced cancer. Palliative Medicine, 11(4), 277-281.
    Navigante, A. H., Cerchietti, L. C., Castro, M. A., Lutteral, M. A., & Cabalar, M. E. (2006). Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. Journal of Pain and Symptom Management, 31(1), 38-47.
    Coyne, P. J., Viswanathan, R., & Smith, T. J. (2002). Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea. Journal of Pain and Symptom Management, 23(2), 157-160.
    Shimoyama, N., & Shimoyama, M. (2002). Nebulized furosemide as a novel treatment for dyspnea in terminal cancer patients. Journal of Pain and Symptom Management, 23(1), 73-76.
    Kohara, H., Ueoka, H., Maeda, T., Takeyama, H., Saito, R., Shima, Y., et al. (2003). Effects of nebulized furosemide in terminally ill cancer patients with dyspnea. Journal of Pain and Symptom Management, 26(4), 962-967.
    Wilcock, A., Corcoran, R., & Tattersfield, A. E. (1994). Safety and efficacy of nebulized lignocaine in patients with cancer and breathlessness. Palliative Medicine, 8(1), 35-38.
    Joyce, M., McSweeney, M., Carrieri-Kohlnman, K. L., & Hawkins, J. (2004). The use of nebulized opioids in the management of dyspnea: Evidence synthesis. Oncology Nursing Forum, 31(3), 551-561.
    Bruera, E., Sala, R., Spruyt, O., Palmer, J. L., Zhang, T., & Willey, J. (2005). Nebulized versus subcutaneous morphine for patients with cancer dyspnea: A preliminary study. Journal of Pain and Symptom Management, 29(6), 613-618.
    Quigley, C., Joel, S., Patel, N., Baksh, A., & Slevin, M. (2002). A phase I/II study of nebulized morphine-6-glucuronide in patients with cancer related breathlessness. Journal of Pain and Symptom Management, 23(1), 7-9.
    Tanaka, K., Shima, Y., Kakinuma, R., Kubota, K., Ohe, Y., Hojo, F., et al. (1999). Effect of nebulized morphine in cancer patients with dyspnea: A pilot study. Japanese Journal of Clinical Oncology, 29(12), 600-603.